Lakefront Biotherapeutics

LKFT

----

Q2 FY2026 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: Lakefront Biotherapeutics(LKFT) the Revenue is 13.83 M (-82.02%), Beat estimate;the EBIT is -49.69 M (+26.03%), Beat estimate;the EPS is 0.0343 (+101.8%), Beat estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueExceed expectations

0.01B82.02%

0.01B90.90%

+0.01B8.88%

EBITExceed expectations

-0.05B26.03%

-0.91B1250.57%

+0.86B1,276.60%

EPSExceed expectations

0.0343101.82%

-13.1324596.84%

+13.1667698.66%

Upcoming earnings report - Q3 FY2026

Available dateNov 11, 2026

Estimate Revenue$46.04 M

Estimate EBIT--

Estimate EPS$0.2618

Revenue

ActualEstimateUnit: USD

Quarterly

EBIT

ActualEstimateUnit: USD

Quarterly

Net income

ActualEstimateUnit: USD

Quarterly

EPS

ActualEstimateUnit: USD

Quarterly